The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36

Clinical Otolaryngology

Volumn 35, Issue 4, 2010, Pages 291-299

  Neary, W J ^a   Hillier, V F ^b   Flute, T ^a   Stephens, S D G ^c   Ramsden, R T ^d   Evans, D G R ^e  

^a WARRINGTON AND HALTON HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY EQUILIBRIUM; CORRELATION COEFFICIENT; HEARING; HEARING IMPAIRMENT; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MENTAL COMPONENT SUMMARY; MOOD CHANGE; NEUROFIBROMATOSIS; PERCEPTION; PHYSICAL COMPONENT SUMMARY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION; WEAKNESS;

ADULT; FEMALE; HUMANS; MALE; MENTAL HEALTH; NEUROFIBROMATOSIS 2; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 77956144864     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2010.02176.x     Document Type: Article

References (12)

1. Evans D.G.R., Huson S., Donnai D. et al. (1992) A clinical study of type 2 neurofibromatosis. Q. J. Med. 84, 603 618
2. Baser M.E., Friedman J.M., Wallace A.J. et al. (2002) Evaluation of diagnostic criteria for neurofibromatosis 2. Neurology 59, 1759 1765
3. Neary W.J., Stephens S.D.G., Ramsden R.T. et al. (2006) Psychosocial effects of Neurofibromatosis type 2 (Part 1). General effects. Audiol. Med. 4, 211 219
4. Neary W.J., Hillier V.F., Flute T. et al. (2010) Use of a closed set neurofibromatosis type 2 questionnaire in measuring the primary and secondary effects of the condition. J. Otol. Laryngol. 124, 720 728
5. Da Cruz M.J., Moffat D.A. Hardy D.G. (2000) Postoperative quality of life in vestibular Schwannoma patients measured by the SF-36 health questionnaire. Laryngoscope 110, 151 155
6. Yardley L., Dibb B. Osbourne G. (2003) Factors associated with quality of life in Meniere's disease. Clin. Otolaryngol. 28, 436 441
7. Neary W.J., Stephens S.D.G., Ramsden R.T. et al. (2006) Psychosocial effects of Neurofibromatosis type 2 (Part 2). Effects on specific systems. Audiol. Med. 4, 211 219
8. Ware J.E., Kosinski M. Dewey J.E. (2000) How to Score Version Two of the SF-36 Health Survey. QualityMetric, Incorporated, Lincoln, RI
9. Ware J.E. Jr. 1993) In SF-36 Health Survey Manuel and Interpretation Guide. The Health Institute, New England Medical Centre, Boston
10. Slattery W.H. III. (2009) NF 2 Natural History Consortium. House Ear Institute. Clinical Trials.gov (Clinical Trials.gov identifier: NCT00004483)
11. Evans D.G.R., Ramsden R.T., Harris R. et al. (1993) Type 2 neurofibromatosis - the need for supraregional care. J. Laryngol. Otol. 107, 401 406
12. R Health Survey, Manual and Interpretation Guide, p. 3.5. QualityMetric Incorporated, Lincoln, RI Manchester